Stockreport

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Vaxcyte, Inc.  (PCVX) 
PDF -- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 Program -- -- VAX-24 Infant Phase 2 Study Enrollment Completed [Read more]